Literature DB >> 1449273

The efficacy of chemotherapy with mebendazole in human cystic echinococcosis: long-term follow-up of 52 patients.

C Bartoloni1, A Tricerri, L Guidi, G Gambassi.   

Abstract

Sixty patients with Echinococcus granulosus infection of the liver, lungs, bone and/or soft tissues were treated for several months with oral mebendazole (50-60 mg kg-1 day-1), in divided doses after fat-rich meals, either without surgery (WS), post-surgery (PS) or pre- and post-surgery (PPS). Long-term follow-up, possible for 52 of the patients, showed that WS, PS and PPS patients have so far remained disease-free following treatment for (means +/- standard deviations) 65.5 +/- 37.7, 82.5 +/- 37.0 and 84.1 +/- 28.3 months, respectively. Ultrasound and computed tomography scans were similar in WS and PPS patients post-treatment. Blood eosinophil levels, which were sometimes elevated initially, returned to normal in all patients and this decrease indicated cyst degeneration before this was evident on the scans. Treatment of patients with cystic echinococcosis may no longer require surgery.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1449273     DOI: 10.1080/00034983.1992.11812661

Source DB:  PubMed          Journal:  Ann Trop Med Parasitol        ISSN: 0003-4983


  6 in total

1.  Progress in the pharmacological treatment of human cystic and alveolar echinococcosis: Compounds and therapeutic targets.

Authors:  Mar Siles-Lucas; Adriano Casulli; Roberto Cirilli; David Carmena
Journal:  PLoS Negl Trop Dis       Date:  2018-04-20

Review 2.  Anthelmintics. A comparative review of their clinical pharmacology.

Authors:  N de Silva; H Guyatt; D Bundy
Journal:  Drugs       Date:  1997-05       Impact factor: 9.546

3.  Mebendazole, an anti-helminth drug, suppresses inflammation, oxidative stress and injury in a mouse model of ulcerative colitis.

Authors:  Moein Eskandari; Fereshteh Asgharzadeh; Mohammad Mostafa Askarnia-Faal; Hamideh Naimi; Amir Avan; Mitra Ahadi; Hassan Vossoughinia; Masoumeh Gharib; Atena Soleimani; Niloufar Naghibzadeh; Gordon Ferns; Mikhail Ryzhikov; Majid Khazaei; Seyed Mahdi Hassanian
Journal:  Sci Rep       Date:  2022-06-17       Impact factor: 4.996

4.  Effects of Isoprinosine on Echinococcus multilocularis and E. granulosus metacestodes.

Authors:  M E Sarciron; S Walbaum; A F Petavy
Journal:  Parasitol Res       Date:  1995       Impact factor: 2.289

5.  Albendazole treatment in cystic echinococcosis: pharmacokinetics and clinical efficacy of two different aqueous formulations.

Authors:  Laura Ceballos; Celina Elissondo; Laura Moreno; Marcela Dopchiz; Sergio Sánchez Bruni; Guillermo Denegri; Luis Alvarez; Carlos Lanusse
Journal:  Parasitol Res       Date:  2008-05-10       Impact factor: 2.289

6.  Mebendazole compared with secnidazole in the treatment of adult giardiasis: a randomised, no-inferiority, open clinical trial.

Authors:  Pedro Almirall; Angel A Escobedo; Idalia Ayala; Maydel Alfonso; Yohana Salazar; Roberto Cañete; Sergio Cimerman; Martha Galloso; Ilmaems Olivero; Maytee Robaina; Karen Tornés
Journal:  J Parasitol Res       Date:  2011-11-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.